Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Clusterin siRNA is a small interfering RNA designed to silence the expression of the clusterin (CLU) gene. Clusterin is a multifunctional chaperone protein involved in various physiological and pathological processes, including apoptosis, cell cycle regulation, and DNA repair. In oncology research, clusterin siRNA is frequently used to sensitize cancer cells (such as prostate, cervical, and leukemia cells) to chemotherapeutic agents like paclitaxel by inhibiting the anti-apoptotic and pro-survival functions of secreted clusterin. It is also utilized in studies of endoplasmic reticulum (ER) stress and renal disease to elucidate the signaling pathways mediated by clusterin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on clusterin siRNA.